Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events

Laboratory Investigation

Volumn 92, Issue 10, 2012, Pages 1451-1460

  Huang, Li ^a,b   Frampton, Gabriel ^a,c   Rao, Arundhati ^c   Zhang, Kun Song ^b   Chen, Wei ^b   Lai, Jia Ming ^b   Yin, Xiao Yu ^b   Walker, Kimberly ^c   Culbreath, Brianne ^c   Leyva Illades, Dinorah ^a,c   Quinn, Matthew ^a,c   McMillin, Matthew ^a,c   Bradley, Michelle ^a   Liang, Li Jian ^b   Demorrow, Sharon ^a,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

biliary cancer; DNA methylation; R1 repressor; SP 1

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CELL DIFFERENTIATION; CELLS; CHOLANGIOCYTE; CONTROLLED STUDY; EPIGENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL SURVIVAL; CHOLANGIOCARCINOMA; CHOLEDOCHAL CYST; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DOPAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MICE; MICE, NUDE; MONOAMINE OXIDASE; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SEROTONIN; SP1 TRANSCRIPTION FACTOR;

EID: 84866861588     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.110     Document Type: Article

References (31)

1. Alpini G, McGill JM, LaRusso NF. The pathobiology of biliary epithelia. Hepatology 2002;35:1256-1268.
2. Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005;41:5-15.
3. Alpini G, Invernizzi P, Gaudio E, et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 2008;68:9184-9193.
4. Coufal M, Invernizzi P, Gaudio E, et al. Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma. I J Cancer 2010;126:2112-2122.
5. Francis H, Demorrow S, Venter J, et al. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. Gut 2012;61:753-764.
6. Hendriks RW, Chen ZY, Hinds H, et al. An X chromosome inactivation assay based on differential methylation of a CpG island coupled to a VNTR polymorphism at the 50 end of the monoamine oxidase A gene. Hum Mol Genet 1992;1:187-194.
7. Pinsonneault JK, Papp AC, Sadee W. Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors. Hum Mol Genet 2006;15: 2636-2649.
8. Zhu QS, Chen K, Shih JC. Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 1994;14:7393-7403.
9. Chen K, Ou XM, Chen G, et al. R1, a novel repressor of the human monoamine oxidase A. J Biol Chem 2005;280:11552-11559.
10. Park J, Tadlock L, Gores GJ, et al. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology 1999;30: 1128-1133.
11. Yokomuro S, Tsuji H, Lunz III JG, et al. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 2000;32:26-35.
12. Hodge DR, Xiao W, Clausen PA, et al. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001;276:39508-39511.
13. Wehbe H, Henson R, Meng F, et al. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 2006;66:10517-10524.
14. Knuth A, Gabbert H, Dippold W, et al. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1985; 1:579-596.
15. Shimizu Y, Demetris AJ, Gollin SM, et al. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 1992;52:252-260.
16. Miyagiwa M, Ichida T, Tokiwa T, et al. A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium. In Vitro Cell Dev Biol 1989;25: 503-510.
17. Storto PD, Saidman SL, Demetris AJ, et al. Chromosomal breakpoints in cholangiocarcinoma cell lines. Genes Chromosomes Cancer 1990;2:300-310.
18. Grubman SA, Perrone RD, Lee DW, et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 1994;266:G1060-G1070.
19. Frampton G, Invernizzi P, Bernuzzi F, et al. Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 2012;61:268-277.
20. DeMorrow S, Francis H, Gaudio E, et al. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol 2008;295:G1150-G1158.
21. DeMorrow S, Glaser S, Francis H, et al. Opposing actions of endocannabinoids on cholangiocarcinoma growth: Recruitment of fas and fas ligand to lipid rafts. J Biol Chem 2007;282: 13098-13113.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) Method. Methods 2001;25:402-408.
23. DeMorrow S, Francis H, Gaudio E, et al. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol 2008;294:G506-G519.
24. Larsen F, Gundersen G, Lopez R, et al. CpG islands as gene markers in the human genome. Genomics 1992;13:1095-1107.
25. Ou XM, Chen K, Shih JC. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 2006;281:21512-21525.
26. Pietrangeli P, Mondovi B. Amine oxidases and tumors. Neurotoxicology 2004;25:317-324.
27. Toninello A, Salvi M, Pietrangeli P, et al. Biogenic amines and apoptosis: minireview article. Amino Acids 2004;26:339-343.
28. Ou XM, Chen K, Shih JC. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci USA 2006;103:10923-10928.
29. Shumay E, Fowler JS. Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches. Epigenetics 2010;5:325-342.
30. Shi Y, Frost P, Hoang B, et al. IL-6-induced enhancement of c-Myc translation in multiple myeloma cells: critical role of cytoplasmic localization of the rna-binding protein hnRNP A1. J Biol Chem 2011; 286:67-78.
31. Voravud N, Foster CS, Gilbertson JA, et al. Oncogene expression in cholangiocarcinoma and in normal hepatic development. Hum Pathol 1989;20:1163-1168.